Loading…
The Archive · 3 posts
Explore innovative healthcare solutions with Uniphar PLC (UPR)! 🌟 Elevating the supply chain across the medical industry with passion and precision. 💡
Showing 2 of 3 posts
Uniphar's 2025 beats expectations with 21% adjusted EPS growth and 1.5x leverage, setting a strong stage for 2026.
JoshuaJanuary 27, 2026
Uniphar's 2025 interims show strong 21% adjusted EPS growth, divisional progress, and strategic momentum. Read the full analysis and key takeaways here.
JoshuaSeptember 2, 2025
Record organic growth drives Uniphar's strongest year since IPO, with Adjusted EPS jumping 21% and a clear path to its €200m EBITDA target.
February 24, 2026